Followers | 85 |
Posts | 6176 |
Boards Moderated | 0 |
Alias Born | 05/27/2009 |
Wednesday, March 24, 2021 8:17:08 AM
GRAY is a $15 potential prior to confirmed data, and then $27++..IMO..
"Graybug Vision Inc (NASDAQ: GRAY) shares are dropped after preliminary data from Phase 2b ALTISSIMO trial of GB-102 for wet age-related macular degeneration (wet AMD).
Investors are reacting to the mean change of best-corrected visual acuity (BCVA) from the baseline that was lower in GB-102 1mg than aflibercept arm.
The mean change from baseline for BCVA for all 20 completers was approximately nine letters lower across all time points versus the study control arm.
The study was designed to evaluate two separate doses of GB-102, 1mg, and 2mg, injected every six months compared with Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Eylea (aflibercept) injected every two months.
After interim safety analysis, the 2mg dose was discontinued after the initial dose, and all patients were switched to 1mg for their second dose.
The median time to first supportive therapy was five months for GB-102 1mg (primary endpoint of the study).
Central subfield thickness of the retina in the GB-102 1mg arm was consistent with the study control arm.
GB-102, the company's lead product candidate, is a microparticle depot formulation of sunitinib malate, injected intravitreally.
Sunitinib is marketed as Sutent by Pfizer Inc (NYSE: PFE).
Piper Sandler has downgraded GRAY to Neutral with a price target of $10 from $27 earlier."
GLTA
.
.
Recent GRAY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/28/2024 10:52:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2024 12:45:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:44:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:39:24 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/29/2024 12:12:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2024 01:53:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2024 01:49:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2024 01:40:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2024 01:39:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2024 01:37:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2024 01:35:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2024 09:12:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2024 12:33:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/29/2024 12:35:33 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/29/2024 12:32:03 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/28/2024 08:48:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2024 11:15:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 10:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/12/2024 05:15:11 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/08/2024 10:55:57 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/08/2024 03:08:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 10:34:17 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/01/2024 09:15:02 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/31/2024 10:12:29 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 09:15:05 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM